White Tea for Prevention of Chemotherapy Induced Mucositis

Status Completed

Clinical Trial Summary

The aim of this study is to determine the effectiveness of mouthwash with white tea in the prevention of paclitaxel induced oral mucositis in women with breast cancer.

Clinical Trial Description

Oral mucositis is a common side effect from paclitaxel treatment. It can be very painful and compromise nutrition and oral hygiene, and it may increase the risk of infection. Although oral mucositis is a common side effect to chemotherapy, no available treatment is yet available that can effectively prevent or treat oral mucositis. Based on the knowledge that white tea has anti-inflammatory, anti-oxidant and anti-microbial effect, the current study aims to assess the effect of mouth wash with white tea on paclitaxel induced oral mucositis in women with breast cancer. This study is a phase II randomized controlled trial in which eligible patients will be allocated to a control group (CG) and a study group (SG). The CG will use salt water with soda for mouthwash eight to ten times a day and the SG will use white tea for mouthwash five to six times a day. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04440930
Study type	Interventional
Source	Vejle Hospital
Contact
Status	Completed
Phase	N/A
Start date	September 2, 2020
Completion date	April 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02229136` - Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus	Phase 2
Terminated	`NCT03843554` - Commensal Oral Microbiota in Head and Neck Cancer	N/A
Enrolling by invitation	`NCT02662374` - Oral Hygiene Regimen in Patients on HCT	Phase 4
Completed	`NCT00938080` - Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck	Phase 1
Completed	`NCT00756951` - Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck Cancer	Phase 2
Completed	`NCT00701688` - Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation	Phase 1
Not yet recruiting	`NCT05059613` - Thalidomide With or Without Probiotics in Radioactive Oral Mucositis	N/A
Completed	`NCT05705622` - The Effect of Nursing Education on Oral Mucositis in Bone Marrow Transplant Patients	N/A
Completed	`NCT02399228` - A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Oral Mucositis	Phase 2
Withdrawn	`NCT02589860` - Analysis of Oral Mucositis in Patient's Undergoing Melphalan Conditioning and Autologous Stem Cell Transplant
Active, not recruiting	`NCT01772706` - Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck Cancer	N/A
Enrolling by invitation	`NCT06122636` - Efficacy of a Probiotic and Microbiological Analysis on Oral Complications Induced by Antineoplastic Therapies in Patients With HNC	N/A
Completed	`NCT03689712` - ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients	Phase 3
Terminated	`NCT02539342` - Caphosol Study: Prevention of Oral Mucositis in Children, Adolescents and Young Adults Receiving Chemotherapy	Phase 3
Completed	`NCT02555501` - Oral Mucositis and Laser Therapy Associated With Photodynamic Therapy	Phase 3
Completed	`NCT01789658` - Cryotherapy for Prevention of Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation	N/A
Completed	`NCT00790322` - Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy	Phase 3
Recruiting	`NCT00549952` - Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients	N/A
Completed	`NCT00289003` - The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Cancer Patients	Phase 2
Completed	`NCT05635929` - Oral Mucositis and Quality of Life With a Mucosa Topical Composition in Head & Neck Cancer Patients.	N/A